{"id":251449,"date":"2012-02-17T13:07:52","date_gmt":"2012-02-17T13:07:52","guid":{"rendered":"http:\/\/www.eugenesis.com\/deutsche-agrees-record-longevity-swap-deal\/"},"modified":"2012-02-17T13:07:52","modified_gmt":"2012-02-17T13:07:52","slug":"deutsche-agrees-record-longevity-swap-deal","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity\/deutsche-agrees-record-longevity-swap-deal.php","title":{"rendered":"Deutsche agrees record longevity swap deal"},"content":{"rendered":"<p><p class=\"meta\">        Deutsche agrees record longevity swap deal      <\/p>\n<p class=\"content-text\">    The swap, announced during Aegon&#039;s results this morning, is    significant for two reasons - its size, and the fact that    Deutsche says it has managed to pass its resulting exposure to    longer Dutch life expectancy on to third parties - anonymous    financial investors in the capital markets.  <\/p>\n<p class=\"content-text\">    These might include other banks, hedge funds, or specialist    insurance-linked securities funds, all willing to bet that    Aegon&#039;s provisions for rising Dutch life expectancy are, in    fact, too high. Deutsche is understood to have \"packaged\" its    exposure from the Aegon deal into various kinds of investment    products for these institutions to buy.  <\/p>\n<p class=\"content-text\">    Usually, when banks and insurers sign longevity deals, they    subsequently pass the risk onto reinsurers - firms that    specialise in covering insurers. But capacity in this market is    limited.  <\/p>\n<p class=\"content-text\">    The \u20ac12bn swap also contains an irony for Aegon, since the    Dutch group had once set out its own plans for entering the    related \"pensions buyout\" market in the UK. Aegon launched a    joint venture with Swiss bank UBS in late 2008 to do this, but    rethought the plans in June 2010, following a restructuring of    its UK life business.  <\/p>\n<p class=\"content-text\">    Deutsche, meanwhile, arrived in pensions swaps with a bang in    January 2010, signing a \u00a33bn longevity deal with BMW on behalf    of its \u00a35bn UK pension fund. It owns a UK insurance subsidiary,    Abbey Life, through which these transactions tend to be    structured.  <\/p>\n<p class=\"content-text\">    Its deal with Aegon today is also one of first large, public    longevity swaps to take place outside the UK. Most of those to    date have involved UK pension schemes, such as those for BMW,    Rolls-Royce and ITV.  <\/p>\n<p class=\"content-text\">    In a statement, Clare Hennings, head of structured insurance    solutions at Deutsche, said: \u201cWe believe this market will    continue to grow as insurance companies and pension funds look    at new ways to manage their liabilities, while investors seek    diversified investment opportunities.\"  <\/p>\n<p class=\"content-text\">    Aegon said this morning that the swap \"reduces required capital    at an attractive cost of capital\", and these deals can be    positive for companies&#039; share prices. Figures from City law    firm Freshfields, released late last month, suggested companies    who reduce financial risks in their pension schemes enjoy an    average 2.1% boost to their shares.  <\/p>\n<p class=\"content-text\">    Yesterday, the UK defence group BAE Systems reported a \u00a31.5bn    write-off related to the deficit in its pension funds,    equalling its 2011 pre-tax profits. The loss is a paper one,    but gives an indication of what could be a bruising valuation    of its \u00a39bn main scheme that is currently underway. If a big    deficit is revealed BAE&#039;s cash payments could be in line for an    increase.  <\/p>\n<p class=\"content-text\">    BAE&#039;s shares were down 7.8p to 325.2p yesterday, though the    market was also disappointed by the firm&#039;s poor trading    prospects.  <\/p>\n<p class=\"content-text\">    Aegon&#039;s deal does not affect its pension scheme, but the    life-expectancy risk in its annuity book is similar. Its shares    were up 0.2% to \u20ac3.95 this morning, as of 11.21am GMT.  <\/p>\n<p class=\"content-text\">    \u2022 Separately, Aegon also said its UK chief executive, who leads    the substantial UK operations that the Dutch group inherited    from its acquisition of Scottish Equitable in 1994, would be    joining its group management board.  <\/p>\n<p class=\"content-text\">    Adrian Grace&#039;s promotion is a \"a reflection of the continued    importance our business in the UK represents within our    strategic priorities\" according to group chief executive Alex    Wynaendts.  <\/p>\n<\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.efinancialnews.com\/story\/2012-02-17\/aegon-longevity-swap\" title=\"Deutsche agrees record longevity swap deal\">Deutsche agrees record longevity swap deal<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Deutsche agrees record longevity swap deal The swap, announced during Aegon&#039;s results this morning, is significant for two reasons - its size, and the fact that Deutsche says it has managed to pass its resulting exposure to longer Dutch life expectancy on to third parties - anonymous financial investors in the capital markets. These might include other banks, hedge funds, or specialist insurance-linked securities funds, all willing to bet that Aegon&#039;s provisions for rising Dutch life expectancy are, in fact, too high. Deutsche is understood to have \"packaged\" its exposure from the Aegon deal into various kinds of investment products for these institutions to buy.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity\/deutsche-agrees-record-longevity-swap-deal.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577495],"tags":[],"class_list":["post-251449","post","type-post","status-publish","format-standard","hentry","category-longevity"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251449"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=251449"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251449\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=251449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=251449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=251449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}